3860.HK
EPS Creative Health Technology Group Limited [3860.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
3860.HK Stock Summary
In the News
3860.HK Financial details
Company Rating
Sell
Market Cap
460M
Income
-64.7M
Revenue
874.16M
Book val./share
0.16
Cash/share
0.27
Dividend
-
Dividend %
-
Employees
132
Optionable
No
Shortable
Yes
Earnings
29 Nov 2023
P/E
-10.76
Forward P/E
-
PEG
-0.4
P/S
1.33
P/B
5.13
P/C
3.07
P/FCF
-11.54
Quick Ratio
1.14
Current Ratio
1.88
Debt / Equity
0.73
LT Debt / Equity
0.44
-
-
EPS (TTM)
-0.13
EPS next Y
-
EPS next Q
-
EPS this Y
159.21%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
0.9%
Revenue Q/Q
100%
EPS Q/Q
101.92%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-18%
ROE
-69%
ROC
-0.34%
Gross Margin
14%
Oper. Margin
-11%
Profit Margin
-12%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.79-1.5
52W High
-
52W Low
-
RSI
38
Rel Volume
3.6
Avg Volume
11.1K
Volume
40K
Perf Week
-15.31%
Perf Month
-12.63%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
-0.125
-
-
Volatility
0.06%, 0.06%
Prev Close
-7.78%
Price
0.83
Change
-9.78%
3860.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.87 | 1.07 | 0.81 | 0.85 | 0.91 | |
| Net income per share | 0.05 | 0.05 | 0.01 | -0.04 | -0.09 | |
| Operating cash flow per share | 0.01 | 0.05 | -0.02 | 0.02 | -0.08 | |
| Free cash flow per share | 0 | 0.05 | -0.03 | 0.02 | -0.08 | |
| Cash per share | 0.16 | 0.2 | 0.17 | 0.4 | 0.26 | |
| Book value per share | 0.22 | 0.25 | 0.27 | 0.25 | 0.18 | |
| Tangible book value per share | 0.22 | 0.25 | 0.27 | 0.25 | 0.18 | |
| Share holders equity per share | 0.22 | 0.25 | 0.27 | 0.25 | 0.18 | |
| Interest debt per share | 0 | 0.01 | 0.01 | 0.02 | 0.02 | |
| Market cap | 242.5M | 260M | 475M | 700M | 555M | |
| Enterprise value | 165.07M | 163.69M | 392.16M | 506.83M | 426.23M | |
| P/E ratio | 8.9 | 11.44 | 73.02 | -39.69 | -12.13 | |
| Price to sales ratio | 0.56 | 0.48 | 1.17 | 1.65 | 1.23 | |
| POCF ratio | 61.36 | 10.55 | -38.36 | 69.68 | -14.56 | |
| PFCF ratio | 239.86 | 10.7 | -36.8 | 70.06 | -13.7 | |
| P/B Ratio | 2.17 | 2.05 | 3.57 | 5.58 | 6.33 | |
| PTB ratio | 2.17 | 2.05 | 3.57 | 5.58 | 6.33 | |
| EV to sales | 0.38 | 0.3 | 0.97 | 1.19 | 0.94 | |
| Enterprise value over EBITDA | 4.87 | 5.43 | 38.71 | -57.42 | -11.25 | |
| EV to operating cash flow | 41.77 | 6.64 | -31.67 | 50.45 | -11.19 | |
| EV to free cash flow | 163.28 | 6.73 | -30.38 | 50.72 | -10.52 | |
| Earnings yield | 0.11 | 0.09 | 0.01 | -0.03 | -0.08 | |
| Free cash flow yield | 0 | 0.09 | -0.03 | 0.01 | -0.07 | |
| Debt to equity | 0 | 0.03 | 0.02 | 0.04 | 0.03 | |
| Debt to assets | 0 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Net debt to EBITDA | -2.28 | -3.19 | -8.18 | 21.89 | 3.4 | |
| Current ratio | 4.4 | 5.04 | 8.21 | 4.99 | 1.88 | |
| Interest coverage | 295.8 | 225.14 | 53.47 | -3.19 | -7.31 | |
| Income quality | 0.12 | 0.89 | -1.74 | -0.6 | 0.79 | |
| Dividend Yield | 0.03 | 0.03 | 0 | 0 | 0 | |
| Payout ratio | 0.28 | 0.35 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.06 | 0.05 | 0.05 | 0.1 | 0.14 | |
| Research and developement to revenue | 0 | 0 | 0 | 0.03 | 0.03 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.74 | -0.01 | 0.04 | -0.01 | 0.06 | |
| Capex to revenue | -0.01 | 0 | 0 | 0 | -0.01 | |
| Capex to depreciation | -2.71 | -0.16 | -0.17 | -0.02 | -0.54 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.52 | 0.51 | 0.28 | 0.45 | 0.6 | |
| ROIC | 0.24 | 0.2 | 0.05 | -0.1 | -0.48 | |
| Return on tangible assets | 0.19 | 0.14 | 0.04 | -0.07 | -0.2 | |
| Graham Net | 0.13 | 0.18 | 0.2 | 0.24 | 0.09 | |
| Working capital | 108.69M | 122.29M | 129.06M | 190.92M | 101.55M | |
| Tangible asset value | 111.91M | 126.53M | 133.15M | 126.7M | 91.41M | |
| Net current asset value | 108.38M | 120.68M | 128.93M | 116.52M | 80.88M | |
| Invested capital | 0 | 0.03 | 0.02 | 0.04 | 0.03 | |
| Average receivables | 11.7M | 23.25M | 32.45M | 46.49M | 53.21M | |
| Average payables | 24.2M | 24.32M | 16.34M | 10.98M | 17.39M | |
| Average inventory | 5.11M | 4.52M | 5.27M | 7.68M | 13.14M | |
| Days sales outstanding | 19.72 | 15.69 | 37.62 | 44 | 44.51 | |
| Days payables outstanding | 26.68 | 18.93 | 9.97 | 12.47 | 21.24 | |
| Days of inventory on hand | 4.64 | 3.76 | 6.19 | 9.48 | 15.99 | |
| Receivables turnover | 18.51 | 23.26 | 9.7 | 8.3 | 8.2 | |
| Payables turnover | 13.68 | 19.29 | 36.61 | 29.27 | 17.19 | |
| Inventory turnover | 78.67 | 97.06 | 58.99 | 38.5 | 22.82 | |
| ROE | 0.24 | 0.18 | 0.05 | -0.14 | -0.52 | |
| Capex per share | -0.01 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.46 | 0.22 | 0.45 | 0.36 | 0.72 | |
| Net income per share | -0.02 | -0.04 | -0.08 | -0.01 | -0.01 | |
| Operating cash flow per share | -0.01 | -0.04 | -0.07 | 0 | 0.01 | |
| Free cash flow per share | -0.01 | -0.04 | -0.08 | 0 | 0 | |
| Cash per share | 0.34 | 0.26 | 0.26 | 0 | 0.27 | |
| Book value per share | 0.23 | 0.18 | 0.18 | 0 | 0.16 | |
| Tangible book value per share | 0.23 | 0.18 | 0.18 | 0 | 0.01 | |
| Share holders equity per share | 0.23 | 0.18 | 0.18 | 0 | 0.16 | |
| Interest debt per share | 0.01 | 0 | 0.01 | 0 | 0.13 | |
| Market cap | 525M | 410M | 555M | 520M | 420M | |
| Enterprise value | 365.22M | 278.53M | 426.23M | 0 | 296.11M | |
| P/E ratio | -16.74 | -5.41 | -3.66 | -49.67 | -20.06 | |
| Price to sales ratio | 2.3 | 3.65 | 2.47 | 2.91 | 1.17 | |
| POCF ratio | -135.73 | -23.35 | -15.24 | 0 | 98.2 | |
| PFCF ratio | -133.69 | -21.88 | -14.32 | 0 | 176.1 | |
| P/B Ratio | 4.56 | 4.68 | 6.33 | 0 | 5.11 | |
| PTB ratio | 4.56 | 4.68 | 6.33 | 0 | 5.11 | |
| EV to sales | 1.6 | 2.48 | 1.89 | 0 | 0.83 | |
| Enterprise value over EBITDA | -185.77 | -15.68 | -11.95 | 0 | -19.76 | |
| EV to operating cash flow | -94.42 | -15.86 | -11.71 | 0 | 69.23 | |
| EV to free cash flow | -93 | -14.86 | -11 | 0 | 124.16 | |
| Earnings yield | -0.01 | -0.05 | -0.07 | -0.01 | -0.01 | |
| Free cash flow yield | -0.01 | -0.05 | -0.07 | 0 | 0.01 | |
| Debt to equity | 0.03 | 0 | 0.03 | 0 | 0.73 | |
| Debt to assets | 0.01 | 0 | 0.01 | 0 | 0.16 | |
| Net debt to EBITDA | 81.27 | 7.4 | 3.61 | 0 | 8.27 | |
| Current ratio | 2.9 | 1.88 | 1.88 | 0 | 1.34 | |
| Interest coverage | -1.3 | -12.85 | -12.74 | 0 | -6.41 | |
| Income quality | 0.49 | 0.93 | 0.96 | 0 | -0.82 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.07 | 0.18 | 0.09 | 0.09 | 0.04 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.05 | 0.03 | 0.03 | |
| Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0.3 | |
| Capex to operating cash flow | 0.02 | 0.07 | 0.06 | 0 | -0.44 | |
| Capex to revenue | 0 | -0.01 | -0.01 | 0 | -0.01 | |
| Capex to depreciation | -0.04 | -0.83 | -0.83 | 0 | -0.36 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.29 | 0.39 | 0.55 | 0 | 0.2 | |
| ROIC | -0.04 | -0.21 | -0.41 | 0 | -0.15 | |
| Return on tangible assets | -0.03 | -0.08 | -0.17 | 0 | -0.02 | |
| Graham Net | 0.17 | 0.1 | 0.09 | 0 | -0.1 | |
| Working capital | 160.93M | 101.55M | 101.55M | 0 | 64.24M | |
| Tangible asset value | 115.9M | 91.64M | 91.41M | 0 | 7.01M | |
| Net current asset value | 107.36M | 80.88M | 80.88M | 0 | -2.58M | |
| Invested capital | 0.03 | 0 | 0.03 | 0 | 0.73 | |
| Average receivables | 54.37M | 59.21M | 57.25M | 0 | 0 | |
| Average payables | 28.72M | 60.86M | 57.7M | 0 | 0 | |
| Average inventory | 13.65M | 15.26M | 16.87M | 0 | 0 | |
| Days sales outstanding | 23.35 | 47.43 | 22.1 | 0 | 20.1 | |
| Days payables outstanding | 13.98 | 83.65 | 10.08 | 0 | 18.78 | |
| Days of inventory on hand | 6.64 | 15.18 | 7.59 | 0 | 7.85 | |
| Receivables turnover | 3.85 | 1.9 | 4.07 | 0 | 4.48 | |
| Payables turnover | 6.44 | 1.08 | 8.93 | 0 | 4.79 | |
| Inventory turnover | 13.55 | 5.93 | 11.86 | 0 | 11.46 | |
| ROE | -0.07 | -0.22 | -0.43 | 0 | -0.06 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
3860.HK Frequently Asked Questions
What is EPS Creative Health Technology Group Limited stock symbol ?
EPS Creative Health Technology Group Limited is a HK stock and trading under the symbol 3860.HK
What is EPS Creative Health Technology Group Limited stock quote today ?
EPS Creative Health Technology Group Limited stock price is $0.83 today.
Is EPS Creative Health Technology Group Limited stock public?
Yes, EPS Creative Health Technology Group Limited is a publicly traded company.
Company Profile
- Volume Average 11.1K
- Market Capitalization 460M
- Employee 132
- CEO Mr. Tatsuji Shimada
- Headquarters Hung Hom,HK
- IPO Date 2017-05-31
-
Website
https://www.epshk.hk 
EPS Creative Health Technology Group Limited, an investment holding company, operates as an apparel supply chain management services provider in Hong Kong, Mainland China, Japan, the United States, Europe, and internationally. The company operates in two segments, Garment and Healthcare. It offers knitwear products comprising women's wear, men's wear, and kid's wear; and apparel supply chain management solutions for its customers ranging from fashion trend analysis, product design and development, sourcing and procurement of materials, production management, quality control, and logistics services. The company is also involved in the provision of development of new drugs, innovative research organization, and medical consultancy services; and provides design and customers account services. It serves owners or sourcing agents of apparel retail brands. The company formerly known as Speed Apparel Holding Limited and changed its name to EPS Creative Health Technology Group Limited in August 2021. The company was founded in 1999 and is headquartered in Hung Hom, Hong Kong. EPS Creative Health Technology Group Limited is a subsidiary of EPS Holdings, Inc.
